Presented by IBC Life Sciences, the 15th annual Well Characterized Biologicals aims to gather industry scientists and FDA regulators to share best practices and regulatory expectations related to a wide spectrum of biological products, including the ever-growing number of complex protein products that are emerging. The event focuses on industry case-studies, analytical strategies and regulatory perspectives related to visible and subvisible particulates; complex antibodies, biosimilars and vaccines; functional assays for biologicals; and novel analytical technology implementation.
Kendall Carey will be presenting on "Novel Bioassays for Monitoring of Antibody Effector Function."
Added by MedImmune on September 26, 2011